Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis.
Michel G, Rocha V, Chevret S, Arcese W, Chan KW, Filipovich A, Takahashi TA, Vowels M, Ortega J, Bordigoni P, Shaw PJ, Yaniv I, Machado A, Pimentel P, Fagioli F, Verdeguer A, Jouet JP, Diez B, Ferreira E, Pasquini R, Rosenthal J, Sievers E, Messina C, Iori AP, Garnier F, Ionescu I, Locatelli F, Gluckman E; Eurocord Group. Michel G, et al. Among authors: verdeguer a. Blood. 2003 Dec 15;102(13):4290-7. doi: 10.1182/blood-2003-04-1288. Epub 2003 Aug 14. Blood. 2003. PMID: 12920027 Free article. Review.
Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation.
Sanz J, Picardi A, Hernández Boluda JC, Martín C, Ferrá C, Nozzoli C, Gonzalez-Vicent M, Rambaldi A, Valcarcel D, Verdeguer A, Serrano D, de Heredia CD, Pascual MJ, de Paz R, Montesinos P, Bartolozzi B, Algarotti A, Sanz MA, Arcese W, Sanz GF; GETH and GITMO. Sanz J, et al. Among authors: verdeguer a. Biol Blood Marrow Transplant. 2013 Sep;19(9):1387-92. doi: 10.1016/j.bbmt.2013.07.004. Epub 2013 Jul 11. Biol Blood Marrow Transplant. 2013. PMID: 23850652 Free article.
Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Piñana JL, Sanz J, Picardi A, Ferrá C, Martino R, Barba P, Gonzalez-Vicent M, Pascual MJ, Martín C, Verdeguer A, de Heredia CD, Montesinos P, Ribera JM, Sanz M, Arcese W, Sanz G; GETH groups; GITMO groups. Piñana JL, et al. Among authors: verdeguer a. Haematologica. 2014 Feb;99(2):378-84. doi: 10.3324/haematol.2013.091009. Epub 2013 Oct 4. Haematologica. 2014. PMID: 24097633 Free PMC article. Clinical Trial.
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.
Sanz MA, Montesinos P, Rayón C, Holowiecka A, de la Serna J, Milone G, de Lisa E, Brunet S, Rubio V, Ribera JM, Rivas C, Krsnik I, Bergua J, González J, Díaz-Mediavilla J, Rojas R, Manso F, Ossenkoppele G, González JD, Lowenberg B; PETHEMA and HOVON Groups. Sanz MA, et al. Blood. 2010 Jun 24;115(25):5137-46. doi: 10.1182/blood-2010-01-266007. Epub 2010 Apr 14. Blood. 2010. PMID: 20393132 Free article. Clinical Trial.
Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia.
Vicent MG, Madero L, Ortega JJ, Martinez A, Gomez P, Verdeguer A, Badell I, Muñoz A, Olive T, Maldonado MS, Bureo E, Cubells J, Diaz MA; Spanish Working Party for BMT in Children (GETMON). Vicent MG, et al. Among authors: verdeguer a. Bone Marrow Transplant. 2002 Jul;30(1):9-13. doi: 10.1038/sj.bmt.1703589. Bone Marrow Transplant. 2002. PMID: 12105771
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens.
Montesinos P, Rayón C, Vellenga E, Brunet S, González J, González M, Holowiecka A, Esteve J, Bergua J, González JD, Rivas C, Tormo M, Rubio V, Bueno J, Manso F, Milone G, de la Serna J, Pérez I, Pérez-Encinas M, Krsnik I, Ribera JM, Escoda L, Lowenberg B, Sanz MA; PETHEMA; HOVON Groups. Montesinos P, et al. Blood. 2011 Feb 10;117(6):1799-805. doi: 10.1182/blood-2010-04-277434. Epub 2010 Dec 8. Blood. 2011. PMID: 21148082 Free article. Clinical Trial.
Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
Ortega JJ, Madero L, Martín G, Verdeguer A, García P, Parody R, Fuster J, Molines A, Novo A, Debén G, Rodríguez A, Conde E, de la Serna J, Allegue MJ, Capote FJ, González JD, Bolufer P, González M, Sanz MA; PETHEMA Group. Ortega JJ, et al. Among authors: verdeguer a. J Clin Oncol. 2005 Oct 20;23(30):7632-40. doi: 10.1200/JCO.2005.01.3359. J Clin Oncol. 2005. PMID: 16234524
Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
Uderzo C, Pillon M, Corti P, Tridello G, Tana F, Zintl F, Nysom K, Galambrun C, Fagioli F, Varotto S, Messina C, Verdeguer A, Urban C, Faraci M, Dini G, Fedeli S, Tichelli A, Rovelli A, Socié G. Uderzo C, et al. Among authors: verdeguer a. Bone Marrow Transplant. 2007 Jun;39(11):667-75. doi: 10.1038/sj.bmt.1705652. Epub 2007 Apr 2. Bone Marrow Transplant. 2007. PMID: 17401396
Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation: report from the EBMT Paediatric Diseases and Late Effects Working Parties.
Uderzo C, Pillon M, Tridello G, Dini G, Urban C, Corti P, Zintl F, Fagioli F, Messina C, Verdeguer A, Faraci M, Fedeli S, Tana F, Tichelli A, Passweg J, Rovelli A. Uderzo C, et al. Among authors: verdeguer a. Pediatr Transplant. 2009 Sep;13(6):719-24. doi: 10.1111/j.1399-3046.2008.01055.x. Epub 2008 Sep 26. Pediatr Transplant. 2009. PMID: 18992061
Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998.
Badell I, Muñoz A, Ortega JJ, Martínez A, Madero L, Bureo E, Verdeguer A, Fernandez-Delgado R, Cubells J, Soledad-Maldonado M, Olivé T, Sastre A, Baro J, Díaz MA; Spanish Working Party for BMT in Children (GETMON). Badell I, et al. Among authors: verdeguer a. Bone Marrow Transplant. 2005 May;35(9):895-901. doi: 10.1038/sj.bmt.1704932. Bone Marrow Transplant. 2005. PMID: 15778727
77 results